| Identification | Back Directory | [Name]
1H-Indole-5-carboxamide, 2-[[4-chloro-2-(trifluoromethyl)phenyl]methyl]-N-[(1R)-1-[4-(ethylsulfonyl)phenyl]-2-hydroxyethyl]-1-(2-fluoroethyl)- | [CAS]
2260631-91-0 | [Synonyms]
1H-Indole-5-carboxamide, 2-[[4-chloro-2-(trifluoromethyl)phenyl]methyl]-N-[(1R)-1-[4-(ethylsulfonyl)phenyl]-2-hydroxyethyl]-1-(2-fluoroethyl)- | [Molecular Formula]
C29H27ClF4N2O4S | [MOL File]
2260631-91-0.mol | [Molecular Weight]
611.05 |
| Hazard Information | Back Directory | [Uses]
RORγ agonist 1 is a potent and orally bioavailable RORγ agonist (EC50 = 21 nM) with antitumor activity. | [References]
[1] Lu B, et al. Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor Activity. J Med Chem. 2021 Oct 28;64(20):14983-14996. DOI:10.1021/acs.jmedchem.1c00828 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|